Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and immunogenicity follow-up after one dose of Lister smallpox vaccine
2006-000715-19Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Lister strain smallpox vaccine in smallpox, sponsored by Sanofi. Primary endpoint: Anti-vaccinia antibody persistence. Started Mar 2006; status: completed.
02
Drugs
Lister strain smallpox vaccine
03
Conditions
smallpox
Beyond the preview
Go deeper on 2006-000715-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000715-19.